‫בס"ד‬
L.E.M Laboratories Ltd.
Founded ISRAEL 2001
Headquarters Nes Ziona, ISRAEL.
Services Cytology and Pathology Diagnosis
Website
www.lem-lab.com
Tel: 00 972 8 9380770
Fax: 00 972 8 9389783
LEM- Laboratories Ltd. is one to the leading and largest provider
of clinical laboratory services in Israel for Histopathology and
Cytopathology using state-of-the-art technologies for a wide range
of diagnostic procedures. It is located in the Kiryat Weizman
Science Park in Nes Ziona, Israel.
The company is accredited by Israel's Ministry of Health, the International
certification for Quality Management System (ISO 9001:2000) and audited by
the
College
of
American
Pathologists
(CAP).
L.E.M-Laboratories have a wide client base, serving for over 10 years, the
private medical sector and the National Health Services as well as
biotechnology
and
pharmaceutical
companies
worldwide.
The company is certified by the Israeli Ministry of Health and is an approved
supplier for laboratory services for the Ministry of Defense, as well as
insurance companies, hospitals and public and private clinics. In addition we
provide research services for Israeli start-up companies to help them in
various research phases.
L.E.M-Laboratories have the International Certification for Quality
Management System (ISO 9001:2000). The entire laboratories activities are
subjected to continuous and strict quality control and audited by the College of
American Pathologists (CAP).
The company's diagnostic high level of expertise is based on experienced sub
specialized senior pathologists, PhD-level scientists, lab technicians and
extensive customer service.
L.E.M-Laboratories provides a fully comprehensive range of
interpretation of biopsies, surgical specimens, fetal autopsies, fine needle
aspirations (FNA) and liquid-based cytology preparations. The company
performs complete diagnostics testing for gynecologic PAP smears, Thin Prep
PAP and HPV DNA testing. Immuno-Histochemistry techniques are run on
daily basis the procedures are available for variety of diagnostic treatments
and
prognostic
requirements.
Biotechnology and Pharmaceutical companies worldwide are engaged with
L.E.M-Laboratories in a wide variety of clinical trials and research projects.
Diagnostic Testing & Services
PATHOLOGY
CYTOLOGY
RESEARCH
L.E.M-Laboratories maintain high service standards and quality standards and
proudly offer a broad ray of specialized services.
Our team of pathologists and cyto-technologists process specimens and
pathology reports for clients worldwide.
We provide our clients with a comprehensive menu of routine and specialty
laboratory tests and services.
Our modern laboratory facilities enable us to offer the convenience in utilizing
one laboratory for all diagnostic testing needs
The medical staff is supervised by Professor Elimelech Okon,
One of the top pathologists in Israel and a world wide renown
pathologist and Hemato-pathologist.
Prof. Elimelech Okon, MD
Medical Director of L.E.M-Laboratories Ltd.
Associate Professor of Pathology, The Hadassah Medical School of the
Hebrew University Jerusalem, Israel Clinical Professor of Pathology - Sackler
School of Medicine , Tel-Aviv University, Tel-Aviv, Israel.
Director of the Department of Pathology, Rabin Medical Center (Beilinson
Campus), Petach-Tiqva, Israel (Till the year 2009).
Visiting Professor, Mallory Institute of Pathology, Boston Medical Center,
Mass., U.S.A.
Director of the Hemato-Pathology Unit, Department of Pathology, Hadassah
Medical Center, Jerusalem, Israel.
L.E.M-Laboratories are providing services to private and general
bodies.
Samples are received from clinics of all major health care providers,
health insurers, private hospitals and physicians.
1. Private physicians send the samples by the mail. The specimens are being
sent in a prepaid padded envelopes.
2. All branches of Assuta hospitals in Israel. (website: www.Assuta.co.il).
a: Assuta Tel Aviv
b: Assuta Haifa
c: Assuta Beer Sheva
d: Assuta Rishon Lezion
e: Assuta Ashkelon
3. Clalit Health Services Ltd.
North district, Center district, Tel Aviv district and South districts.
(Website: www.clalit.co.il).
4. Israel Ministry of defense forces. (Website: www.mfa.gov.il).
5. Private Insurance companies:
a: Clal. (Website: clalbit.co.il/healthdivision).
b: Phoenix. (Website: www.phoenixhealthfund/fund.com.au/about.asp)
c. Harel. (Website: www.saatch-interactive.co.il/Harel).
Specimens are transported daily to the main lab facility by a fleet of drivers.
Specimens from abroad maybe be delivered by all international couriers or
brought to us personally.
Histopathology
L.E.M-Laboratories is primarily engaged in routine histological as well as
special histochemical staining methods, processing and interpretation of
biopsies, operative specimens, fine needle aspirations (FNA) and cytological
preparations.
The following biopsies are diagnosed on daily basis:











General Surgical Pathology
Dermatology
Gastrointestinal
Genitourinary
Gynecology
Kidney Pathology
Lymph Node Hematopathology
Orthopedic
Pediatric
Pulmonary
Deontology Pathology
In addition to the above listed items, L.E.M-Laboratories activities include
Immuno-histochemical procedures with a large battery of antibodies to cellular
components and specific tumor markers (Prognostic and Therapeutic), as well
as the use of ancillary new diagnostic techniques.
L.E.M-Laboratories are an approved importer of human tissue specimen by
the Israeli Health Authorities.
We also offer second opinion or consultation services given by the best
pathologists worldwide. Opportunities for clinicians to review diagnostic slides
are also available.
L.E.M Laboratories guarantee the best results for a quick and reliable
diagnosis. Using the state of the art equipment, top quality laboratory
materials and skilled technicians and pathologists.
The Following tests are available at our Cytology Laboratory:
General cytology








Examination of fine needle aspirations of superficial masses and deep
seated organs
All body fluids
Bronchial smear / brushings and washings
Sputum cytology
Gastrointestinal brushing
Urine cytology
Impression smear
Scrapings cytology - skin, eye etc.
The Head Cytopathologist of L.E.M Laboratories:
Dr' Herbet Mehrdad
Chief cytologist: Mrs. Rela
Herivan
Gynecological cytology
Special stains and ancillary tests





Papanicolaou
Giemsa
Stains for fungi, bacteria and parasites
Immunoperoxidase
HPV DNA testing using the method from Greiner Germany
General Cytopathology
We also assess Fine Needle Aspirations (FNA) and Fine Needle Aspiration
Biopsies (FNAB).
Liquid-base cytology is done on daily basis for Sputum cytology,
Gastrointestinal brushing, Urine cytology, Impression smear, Scrapings
cytology - skin, eye etc.
In addition to the above listed items, L.E.M-Laboratories activities include
Immunohistochemical procedures with a large battery of antibodies to cellular
components and specific tumor markers, as well as the use of auxiliary new
diagnostic techniques.
Immunohistochemistry procedures are done according the necessities to all
specimen sources such as:
Solid Tumors, Soft Tissue Tumors, Metastatic Tumors, Neoplastic Cells of
Ascitic & Pleural Effusions, Lymphoma
Neuroendocrine Tumors, and Undifferentiated Neoplasms.
Cytological evaluation (as well as all other services) is available for specimens
of human origin as well as of veterinary origin.
Collection of specimens from clients follows the same method as with other
pathologic specimens.
The cytology program at L.E.M-Laboratories is patient focused and service
driven to provide the highest quality service to the clinician.
Gynecological Cytopathology
We accept all gynecological-related specimens such as cervical and
endometrial specimen.
Real-time correlations between a patient's prior abnormal Pap smear read at
L.E.M-Laboratories and her current cervical biopsy aids our clients in
providing quality care for their patients.
Advances in technology are changing the way in which cytopathology and
Pap smear screening are practiced. At L.E.M -Laboratories, we closely
monitor new developments in technology. We focus our attention on the
products and services that improve quality and bring value to our clients and
patients.
Cervical cancer is one of the most preventable cancers. The Papanicolaou
(Pap) smear test has been used to screen for pre-cancerous lesions in
asymptomatic women for the past 50 years.
The Pap test - the generic term for the type of test developed by Dr'. George
Papanicolaou, used to screen for signs of cervical cancer.
L.E.M-Laboratories offer the Thin-Prep liquid-based cytology service. This is
especially valuable for gynecological samples, as other ancillary
investigations, such as HPV sub-typing.
The Pap (or cervical) smear:
a: the conventional method for Pap testing that involves smearing a
portion of a woman's cervical cell sample onto a glass slide.
b: The liquid based Thin Prep Pap Test - Hailed as a revolutionary
development in cervical cancer screening, clinical studies have proven that
the Thin Prep Pap Test is far more effective in the early detection of
precancerous cells. It involves a different process whereby virtually the
entire cervical cell sample is rinsed into a vial, hence the same samples
can then be re-used to screen for HPV.
Thin Prep:
Consultation and second opinion services are available by our senior
pathologists.
We often receive slides from other laboratories, hospitals, pharmaceutical
companies, biologically oriented academic institutions, biotechnology
companies, independent clinicians, dentists and veterinarians from Israel as
well as from abroad.
Raw pathological material may arrive from these sources for re-processing
and examination in order to give a second opinion diagnosis.
Our pathologists, with outstanding reputations for their professional diagnostic
skills, are available to provide advice in the following areas:













Gynecology
Kidney Pathology
Lymph Node Hematopathology
Pediatric
Orthopedic
General Surgical Pathology
Pulmonary
Cytology
Veterinary Pathology
Deontology Pathology
Dermatology
Gastrointestinal
Genitourinary
Our research projects team can provide advice regarding any
laboratory related aspects of their studies.
Guidelines for Specimen Preparation
Specimen Handling For Routine Submissions:
Totally immerse immediately each specimen in a tightly secured container
with 10% neutral buffered formalin
Use a separate container for each specimen
Do not crush the specimen with forceps, hemostats, or other instruments.
Cautery will cause heat artifact.
DO not freeze the specimens.
Do not force a large specimen into a small container. Formalin volume to
specimen ratio should be 10:1.
Label each container (not the lid) with patient's name and source of specimen.
Complete a Histopathology test requisition and send with specimen.
Each container and specimen must be separately identified on the test
requisition.
The test requisition should contain patient's date of birth, sex, clinical
information and anatomic source of tissue.
We can accept wet specimens, paraffin blocks or pre-prepared slides. All
samples are organized and accurately logged and tracked by trained
professionals, ensuring integrity of the process. All pre-prepared blocks and
slides are returned and residual wet tissue can also be returned if required.
Specimen Handling For Immunohistochemistry (IHC):
IMUNOHISTOCHEMICAL
Submit formalin fixed paraffin embedded blocks/4m sections on coated glass
slides. Preferably submit one routinely stained H & E section of the block with
appropriate clinical history and copy of Histopathology report
Alternatively submit specimens as for Routine Histopathology
Unstained FNA smears are also acceptable. Submit 2 smears for each
marker requested.
Expertise of the Diagnostic Team
L.E.M-Laboratories Senior Staff of MD's includes leading Pathologists in
General Surgical Pathology with a variety of sub-specialties:
1. Prof. Elimelech Okon, MD (Hemato-Pathology)
Medical Director of LEM-Laboratories Ltd.
Associate Professor of Pathology, The Hadassah Medical School of the Hebrew
University Jerusalem, Israel Clinical Professor of Pathology - Sackler School of
Medicine , Tel-Aviv University, Tel-Aviv, Israel.
Director of the Department of Pathology, Rabin Medical Center (Beilinson Campus),
Petach-Tiqva, Israel (Till the year 2009).
Visiting Professor, Mallory Institute of Pathology, Boston Medical Center, Mass. ,
U.S.A. Director of the Hemato-Pathology Unit, Department of Pathology, Hadassah
Medical Center, Jerusalem, Israel.
2. Dr. Herbert Mehrdad – Senior Pathologist - Asaff Harofeh Hospital
and LEM Lab Diagnostics.
3. Dr. Tovar Anna – Senior Pathologist – Belinson Hospital and LEM
Lab Diagnostics.
4. Dr. Stranov Julia – Senior Pathologist – Belinson Hospital and LEM
Lab Diagnostics.
5. Dr. Schwartz Ignat – Senior Pathologist – Tel Hashomer Hospital and
LEM Lab Diagnostics.
6. Dr. Fridman Eduard -Senior Pathologist – Tel Hashomer Hospital and
LEM Lab Diagnostics.
7. Dr. Volkov Alexander –Senior Pathologist – Tel Hashomer Hospital
and LEM Lab Diagnostics.
8. Dr. Diment Judith – Senior Pathologist – Kaplan Hospital and LEM
Lab Diagnostics.
9. Dr. Open Magda – Senior pathologist – former Kaplan Hospital and
LEM Lab Diagnostics.
10. Dr. Cagnano Emanuela – Senior Pathologist –Ichilov Hospital and
LEM Lab Diagnostics.
11. Dr. Katz Semion – Senior Pathologist – former Wolfson Hospital and
LEM Lab Diagnostics.
12. Dr. Konichezky – Senior Pathologist – Belinson Hospital and LEM Lab
Diagnostics.
13. Dr. VeltmanVladimir –Senior Pathologist former Belinson Hospital and
LEM Lab Diagnostics.
14. Dr. Kravtsov Vladimir – Senior Pathologist – Meir hospital and LEM
Lab Diagnostics.
15. Dr. Sukemanov Oleg – Senior Pathologist – Wolfson Hospital and
LEM Lab Diagnostics.
Quality Management
L.E.M- Laboratories has a total commitment to quality.
There is a formal Quality Assurance Program, which provides a systematic
method for continually monitoring and evaluating the quality of our laboratory
service.
The ultimate goal of the Quality Assurance Program is to ensure the delivery
of the highest possible level of patient care. This includes maximum
diagnostic accuracy by dual pathologist's review of every case, external
consultation of difficult cases by nationally recognized physicians, timely
reporting of test results, effective communication with clinical staff, and
appropriate utilization of laboratory services.
Quality Assurance includes in-house consultation and case reviews, as well
as on-request consultation.
Each department at L.E.M Laboratories has a senior scientist overseeing and
maintaining quality.
The company is certified by the Israeli Ministry of Health and is an approved
supplier for laboratory services for the Ministry of Defense.
L.E.M-Laboratories are accredited by the International certification for Quality
Management System (ISO 9001:2000).
Quality management is being led by Mr. Zion Mymon Deputy Head Manager of
L.E.M Laboratories.
The entire laboratories activities are subjected to continuous and strict quality
control and audited by the College of American Pathologists (CAP). The
College of medical society serving more than 15,000 physician members and
the laboratory community throughout the world. It is the world's largest
association composed exclusively of pathologists and is widely considered the
leader in providing laboratory quality improvement programs.
Our laboratory routinely utilizes several controls to ensure that each assay run
has been performed appropriately and according to protocol specifications.
Control slides and tissue sections are tested alongside a patient's tissue
sample each time the assay is performed.
LEM-Laboratories ensures sufficient resources and management time
devoted to quality. Increasing our clinical trial work and associated quality
inspections we have extended scientifically the quality management
operations.
We, at LEM-Laboratories, have been and continue to be committed to the
highest of ethical standards in the conduct of our healthcare and business
operations.
We demand of ourselves full compliance with all local laws. We are committed
to preventing, detecting, and disciplining any unethical behavior.
Publications
BOOK
Immune Systems and Human Intrauterine Development
Itzhak Zusman, Pavel Gurevich, Herzel Ben-Hur.
Published by Transworld Research Network
Trivandrum-695 023, Kerala, India pp 1-238, 2008.
B1 ORIGINAL ARTICLES
1. Gurevich P, Ben-Hur H, Szvalb S, Moldavsky M, Zuzman I.
Lymphoid-Epithelial secretory immune system in human fetuses in the second trimester of gestation.
Pediatric and developmental pathology; 5, 22-28, 2002.
2. Ben-Hur H, Chohen O, Shcneider D, Gurevich P, Halperin R, Bala U, Mozes M, Zusman I.
The role of lymphocytes and macrophages in human breast tumorigenesis: An immunohistological and
morphometric study.
Anticancer Res; 22, 1231-1238, 2002.
3.
Kossoy G, Ben Hur H, Lifschitz O, Zusman I. Mammary tumors in splenectomized rats.
Oncology reports 9: 185-188, 2002.
4. Ben-Hur H, Kossoy G, Zandbank J. Zusman I.
Response of the immune system of mammary tumor-bearing rats to cyclophosphamine and soluble lowmolecular mass- tumor- associated antigens: Rate of lymphoid infiltration and distribution of T lymphocytes in
tumors.
Int J Molec Med; 9, 425-430, 2002.
5. Ben-Hur H, Kossoy G, Zusman I.
Soluble low-molecular-mass tumor-associated antigens prompt the suppression of rat mammary tumors by
tamoxifen and prevent its toxic effect.
Int J Oncol; 20, 413-7, 2002.
6. Ben-Hur H, Kossoy G, Schneider DF, G, Zandbank J. Zusman I.
Response of the immune system of mammary tumor-bearing rats to cyclophosphamine and soluble lowmolecular mass- tumor- associated antigens, the spleen and lymph nodes.
Int J Molec Med.; 9 (3), 311-6, 2002.
7. Ben-Hur H, Kossoy G, Kossoy N, Zusman I.
Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble lowmolecular-mass tumor-associated antigens: The bone marrow and thymus.
Int J Molec Med; 10, 517-521, 2002.
8. Ben Hur H, Kossoy G. Yarden G, Kossoy Nadia, Zusman I.
Effect of cyclophosphamide and soluble tumor-associated antigens on lyphoid infiltration, proliferative activity
and rate of apoptosis in chemically-induced rat mammary tumors.
In Vivo; 16, 287-292, 2002.
9. Kossoy G. Stark A, Tendler Y, Ben-Hur H, Beniashvili D, Madar Z, Zusman I.
Transplacental effects of high fat diets on functional activity of the spleen and lymph nodes, cell kinetics and
apoptosis in mammary gland tumors in female rat offspring.
Int J Molec Med; 10, 773-778, 2002.
10. Ben-Hur H, Mordechay E, Reuvit H, Gurevitch P, Zandbank J, Meherdad H, Zusman I.
Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.
Oncol Rep; 9, 977-980, 2002.
11. Ben-Hur H, Kossoy G, Lifschitz O, Zusman I.
Splenectomy, Chemically-induced mammary tumors and thymic lymph nodes in rats: Experimental and
morphological studies.
In vivo: 16, 275-280, 2002.
12. Kossoy G, Ben Hur H, Lifschitz O, Zusman I.
Mammary tumors in splenectomized rats.
Oncology reports 9: 185-188, 2002.
13. Gurevich P, Elhayany A, Ben-Hur H, Moldavsky M, Sergio S, Zandbank J, Schneider DF, Zusmann I.
Secretory components, J chain and Immunoglobulins in human embryos and fetuses of the first trimester of
pregnancy: an immunohistochemical study.
Pediat Dev Pathol; 6, 35-42, 2003.
14. Gurevich P, Elhayany A, Ben-Hur H, Moldavsky M, Sergio S, Zandbank J, Sperling I, Zusmann I.
An immunohistochemical study of the secretory immune system in human fetal membranes and decidua of the
first trimester pregnancy.
Am J Reprod. Immunol; 50(1), 13-19, 2003.
15. Kossoy G, Zandbank J, Tendler E, Anisimov V, Khavinson V, Popovich I, Zabezhinski M, Zusman I, Ben-Hur H.
Epitalon and colon carcinogenesis in rats: Proliferative activity and apoptosis in colon tumors and mucosa.
Int J Molec Med; 12, 473-477, 2003.
16. Kossoy G, Ben Hur H, Avinoach I, Elhayany A, Shneider DF, Zuzmann I.
Human soluble tumor- associated antigens promote the suppression of rat mammary tumors by 5-fluorouracil
and stimulate the functional activity of immune organs: Experimental and morphological studies.
Int J Molec Med; 12(5), 797-801, 2003.
17. Kossoy G, Avinoach I, Zuzmann I, Shneider DF, Ben Hur H, Elhayany A.
Human soluble p66 and p51 tumor- associated antigens promote the suppression of rat mammary tumors in
comparison to commercial human albumin.
Oncol Rep; 11(2), 487-91, 2004.
18. Ben Hur H, Kossoy G, Sanko H, Geva D, Shumlin N, Zuzmann I.
Response of T- and B- lymphocytes in the spleen of mammary tumor- bearing rats to treatment with tamoxifen
and soluble tumor-associated antigens.
Oncol Rep; 12(1), 181-5, 2004.
19. Ben Hur H, Kossoy G, Mehrdad H, Elhayany A, Zuzmann I.
Response of T and B lymphocytes in the spleen, lymph nodes and mammary tumors in rats treated with human
soluble tumor-associated antigens and commercial human albumin.
Oncol Rep; 12(6), 1329-33, 2004.
20. Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Zusman I.
Rat soluble tumor-associated antigens inhibit chemically-induced mammary tumorigenesis in syngeneic rats.
Oncol Rep; 13(4), 585-8, 2005.
21. Ben Hur H, Gurevich P, Elhayany A, Avinoach I, Schneider DF, Zuzmann I.
Transport of maternal immunoglobulins through the human placental barrier in normal pregnancy and during
inflammation.
Int J Molec Med; 16(3), 401-7, 2005.
22. Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Kossoy N, Zusman I.
Preventive effect of the soluble tumor-associated antigens on DMBA induced tumorigenesis in C3H/He mice
oncology.
Oncol Rep; 14(6), 1625-9, 2005.
23. Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Kossoy N, Zusman I.
Effects of tamoxifen and soluble tumor-associated antigens on ovarian structure in mammary tumor-bearing
rats.
Oncol Rep; 14(5), 1317-21, 2005.
24. Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Zusman I.
The morphological pathway for mouse forestomach cancer.
Oncol Rep; 15(2), 479-83, 2006.
25. Kossoy G, Anisimov VN. Ben-Hur H, Zusman I.
Effect of synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice.
In Vivo; 20(2), 253-7, 2006.
26. Kossoy G, Ben-Hur H, Miskin R, Zusman I.
Tumor target organs and rate of survival in long-living transgenic mice and their parental wild-type counterparts
exposed to the carcinogen dimethylbenz(a)anthracene.
In Vivo 20(4):543-8 2006
27. Gurevich P, Elhayany A, Milovanov AP, Halperin R, Kaganovsky E, Zusman I, Ben-Hur H.
The placental barrier in allogenic immune conflict in spontaneous early abortions: immunohistochemical and
morphological study.
Am J Reprod Immunol. 2007 Nov;58(5):460-7.
(ISI category: Reproductive biology; Rank: 17/24; IF=1.416)..
28. Sally Metsuyanim, Orit Harari-Steinberg, Ella Buzhor, Dorit Omer, Naomi Pode- Shakked, Herzel Ben-Hur,
Reuvit Halperin, David Schneider, Benjamin Dekel. Expression of Stem Cell Markers in the Human Fetal
Kidney.
PLoS ONE 2009.21;4(8):e6709.
In general
Blocks and slides are kept without time limit in the archives of L.E.MLaboratories.
All projects are fully confidential handled in accordance with the strict
regulations of the Israeli law.
The laboratory is supported by a sophisticated database which delivers
performance and flexibility to the registration, analysis and reporting
processes.
This state of the art application permits bar-coded samples to be tracked
throughout the laboratory, down to the individual aliquot level. Results are
transmitted electronically to prevent errors to allow interpretive diagnostic
comments to be added.
An extensive network linking to our customers allows downloading of
pathology results directly to Doctor's computers that ensures close working
relationships with clinical colleagues and consistency of reporting.
Customer Service
An extensive network linking to our customers allows downloading of
pathology results directly to Doctor's computers that ensures close working
relationships with clinical colleagues and consistency of reporting.
Customized reports available to meet all clinicians needs, the Pathologists in
L.E.M Laboratories are always available for telephone consultations.
Delivery of reports
Traditional hard copies are delivered in all cases, in addition to faxes on
request. In addition to our enthusiastic office team, who are ready to assist
with routine enquiries, our Consultant staff is available, at all times, to discuss
cases and offer advice.
Notification is performed for all significant abnormal results.
Secretorial management
Results are being sent by mail, fax and through the computer on demand.
Specimen collection
Regular routine collection runs are available in addition to special collection
on request. Specimens are collected by our specialist couriers, in compliance
with all Health & Safety requirements.
L.E.M-Laboratories, arranges on special request, specimen pick-up from your
facility at your convenience either via personal or commercial courier service.
Turnaround times
Turnaround Time - Every effort is put in place to return routine diagnostic
interpretive reports within 48 to 72 hours.
Cytology Test Per Year : 60,000
Pathology Test Per Year: 60,000
L.E.M. LABORATORIES STANDARDS,
SEE ATTACHED SEPARATE FILE.
L.E.M-Laboratories are providing services to private and general
bodies.
Samples are received from clinics of all major health care providers,
health insurers, private hospitals and physicians.
1. Private physicians send the samples by the mail. The specimens are being
sent in a prepaid padded envelopes.
2. All branches of Assuta hospitals in Israel. (website: www.Assuta.co.il).
a: Assuta Tel Aviv
b: Assuta Haifa
c: Assuta Beer Sheva
d: Assuta Rishon Lezion
e: Assuta Ashkelon
3. Clalit Health Services.
North district, Center district, Tel Aviv district and South districs. (Website:
www.clalit.co.il).
4. Israel Ministry of defense forces. (Website: www.mfa.gov.il).
5. Private Insurance companies:
a: Clal Health Insurance. (Website: clalbit.co.il/healthdivision).
b: Phoenix Health Insurance. (Website:
www.phoenixhealthfund/fund.com.au/about.asp)
c. Harel Health Insurance. (Website: www.saatchinteractive.co.il/Harel).
ASSUTA HOSPITAL IN TEL AVIV ISRAEL
Assuta – Israel’s largest and leading private medical services center
Assuta Medical Center offers advanced medical treatments and world-class
equipment and technologies to ensure optimal outcomes for patients. Assuta
is synonymous with excellence in healthcare, and is the name Israelis trust
with their health and the health of their families. At the Assuta Medical
Tourism Center, patients from abroad can also benefit from the Assuta
advantage.
Assuta' Servicer
Each year, Assuta provides approximately 85,000 operations, 650,000
ambulatory checks and treatments, 235,000 imaging tests (such as MRI and
CT), 5,000 heart catheterization procedures and 5,000 IVF treatments. Each
treatment at Assuta, whether minor or major, is conducted with the highest
quality of care and proficiency.
Clalit Health Services
Clalit Health Services, Ltd. operates as a health organization in Israel. It owns
and operates primary care clinics, specialty care health centers, and
specialized health centers, such as women's health care centers, pediatric
health care centers, multi-specialty centers for adolescents, sports medicine
centers, and health centers for travelers. The company also operates general
hospitals, rehabilitation, mental health, medical research, care for the elderly,
teaching and training, children's medical centers, and other paths of healing
centers, as well as pharmacies, dental clinics, laboratories, diagnostic
imaging, and specialist centers. In addition, it offers health insurance and
medical . One of Clalit’s unique features is its total involvement in the health
services it offers. It plans, builds, owns and operates its own modern health
care facilities, and also leases clinic space in centrally located places such as
shopping malls, on a long term basis. It employs as salaried personnel the
nurses and doctors, teachers, researchers and administrators who staff its
hospitals and clinics, including 7,500 physicians, 11,500 nurses, 1,300
pharmacists, 4,400 paramedics and laboratory/imaging technicians and 9,400
administrative personnel
Clalit has adopted a decentralized form of organization, in which the country is
divided into 8 districts. Each district has wide scope of independence in
decision-making. The districts vary in size from some 340,000 members to
over 600,000 members, and are responsible for a varying number of clinics,
ranging from 60 to more than 180. Budgeting is based on a capitation system.
Each district is headed by an executive board. Day-to-day supervision of the
services provided in the clinics is assigned to smaller regional offices
Migdal Health Insurance
Migdal Group is the leading insurance and finance company in Israel. For 75
years, Migdal has been providing a wide variety of insurance, pension and
financial assets management services products in the long run. Migdal Group
and its subsidiaries serve over one million and a half individual and business
customers.
Migdal Insurance Company was founded in 1934, in Jerusalem, by families of
businessmen who operated under the mandate, a group of Jewish families
from Alexandria and the Italian insurance company Generali.
Health Sector
The Health Department initiates, formulates and managges collective healthcare insurance for dozens of the leading bodies in Israel, as well as a range of
unique health insurance plans adapted for the needs of private clients.
The Company was established on January 1, 2006, following a merger
between Aryeh Insurance Company and Clal Insurance.
In March 2006 , the structural reorganization was completed ; the company’s
life and non- life business was transferred to Clal insurance on January 1st
2006, and the Health and Long Term Care Insurance business, was
transferred from Clal Insurance to the Clal Health company .
The establishment of Clal Health as an independent Insurance Company
reflects the great importance of the Health insurance sector to Clal Group .
The company focuses on the development of the Health Insurance Sector and
its operations are continually growing. Clal Health holds 17% of the local
Health Insurance market, which ranks the company as the second largest in
Israel.
The Company offers a variety ofadvanced products which the public health
system cannot supply and provides high-end Health insurance solutions to its
clients.
The health division main product lines are insurance to individuals, groups,
overseas travel insurance, insurance for foreign workers, long term care
insurance and insurance for Israelis residing overseas.
Phoenix Health Insurance
1949 - company was founded by the late David Hachmi
1978 - Phoenix shares issued to the public on the Tel Aviv Stock Exchange
2002 - Control acquired by Mayer Group
2004 - Operational merger: Israel Phoenix and Hadar
2006 - Acquisition of 40% of Excellence Nessuah – the leading investment
house in Israel
2006 - Control acquired by Delek Group
Phoenix was founded by the late David Hachmi in 1949. He was the one who
determined that the company's vision would be based on caring for personal
welfare and securing one's future and the future of next generations. This
vision was and remains one of the company's mainstays.
Since its establishment, Phoenix has consistently placed personal devoted
attention to you – its costumers – at the forefront of its corporate philosophy,
along with caring for your present and future security, while providing to your
needs in all aspects of life.
Phoenix is a Company of people working on behalf of people, a Company that
believes in its costumers, its agents and its employees and that will stand by
them in difficult times.
Phoenix Holding Ltd. consists of two principal branches. The first branch is
Phoenix Insurance Company Ltd.; While the second branch is Phoenix
Investments and Finance Ltd. – holding joint control over Excellence Nessuah
Investments House.
Phoenix Corporation enjoys considerable stability thanks to its diversified
holding structure and the intelligent management of investments and capital.
Health Line
Private medicine within reach! Coverage for medical treatment, surgery,
transplants in Israel and worldwide, pharmaceuticals and more. Phoenix
insurance products guarantee the best possible medical treatment that money
can buy. Half a million households own Phoenix health insurance.
General Insurance
This sector includes all individual and commercial property insurance:
Homeowners' insurance, compulsory and comprehensive automotive
insurance, various liability insurance, marine insurance, engineering
insurance and more.
Phoenix Investments and Finance
Phoenix Investments and Finance Ltd. is responsible for investing the
members' funds and for the company's own investments an finances –
primarily through its holdings (joint control) in Excellence Nessuah
Investments House.
Harel Health Insurance
Harel Insurance Company Ltd (Harel). is a private company, fully owned by
Harel Insurance Investments and Financial Services Ltd. (Harel Group) - one
of Israel's largest public companies, whose shares are traded on the Tel Aviv
Stock Exchange.
Harel Group is the third largest insurance group in Israel. It is the second
largest in general insurance; the market leader in health insurance, and from
the perspective of premium volume, it is the third largest in life insurance.
Harel contains almost all the insurance activity that Harel Insurance
Investments & Financial Services has acquired over time: Harel, which was
established by the Group in 1975, Shiloah (acquired in 1984), the Yardeniya
portfolio (1985), Sahar (1989), and Zion (1999). The last stage of this process
took place on January 1, 2003, when Sahar-Zion merged with Shiloah, which
then changed its name to Harel Insurance Company Ltd. - the name of the
company that initiated the Group's insurance business in 1975.
Harel Insurance works closely with the world's largest reinsurance companies
as well as with Lloyd’s. Harel was also chosen as the Global Partner for
multinational corporations such as AXA, Allianz, Royal & Sun Alliance, Ace
and Chubb, and insures the Israeli branches of several large, international
companies operating in Israel.
With more than 70 years reputation and experience, Harel provides
comprehensive insurance solutions to hundreds of thousands of policyholders
in all areas: general insurance, life insurance and long term savings (provident
funds, pension funds), health insurance, travel insurance, homeowners'
insurance, business insurance and motor insurance.
The Harel Group's strength, firm economic backbone, highly qualified staff
and the personal service it provides enable it to offer you peace of mind and
the secure knowledge that your money and future are in the most reliable and
professional hands.